OR WAIT null SECS
June 01, 2020
The acquisition gives Novovax an annual operating capacity of more that one billion doses of COVID-19 vaccine antigen.
May 28, 2020
The new facility in County Mayo includes an ISO class 7 cleanroom for the manufacturing of single-use systems.
May 26, 2020
The 60,000-ft2 facility will work in conjunction with the company’s Kakegawa, Japan, clinical supply facility to serve local and global biotech and pharmaceutical companies.
May 20, 2020
US manufacturers focus on preparing capacity while vaccines and treatments for COVID-19 are being developed and tested.
May 19, 2020
Evonik opened a new facility for GMP manufacturing of bioresorbable polymers and excipients for pharmaceutical and medical applications in Birmingham, AL.
May 13, 2020
The company will invest $180 million to construct a new 290,000-ft2 facility in Plainville, MA.
May 06, 2020
The center will be located at NJIT’s Life Sciences and Engineering center and will feature two good manufacturing practices suites that are expected to be completed and operational during the summer of 2020.
Remote, machine health monitoring services reduce the need for on-site visits.
May 01, 2020
The goal of the collaboration is to manufacture up to one billion does per year of mRNA-1273, Moderna’s vaccine against the novel coronavirus.
April 16, 2020
The technology center is dedicated to developing greener, safer chemistries for manufacturing pharmaceutical raw materials and intermediates.